Alliance Pharma plc is a drug manufacturers-specialty & generic business based in the UK. Alliance Pharma shares (APH.LSE) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. Alliance Pharma employs 200 staff and has a trailing 12-month revenue of around £131.3 million.
|Latest market close||N/Ap|
|52-week range||54.862p - 91p|
|50-day moving average||82.5294p|
|200-day moving average||75.8331p|
|Wall St. target price||116p|
|Dividend yield||0.01p (1.23%)|
|Earnings per share (TTM)||2.1p|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Alliance Pharma stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Alliance Pharma's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Alliance Pharma's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 42x. In other words, Alliance Pharma shares trade at around 42x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Alliance Pharma's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £37 million.
The EBITDA is a measure of a Alliance Pharma's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||£131.3 million|
|Operating margin TTM||25.25%|
|Gross profit TTM||£86.1 million|
|Return on assets TTM||5.14%|
|Return on equity TTM||4.18%|
|Market capitalisation||£464.7 million|
TTM: trailing 12 months
Dividend payout ratio: 25.65% of net profits
Recently Alliance Pharma has paid out, on average, around 25.65% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.23% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Alliance Pharma shareholders could enjoy a 1.23% return on their shares, in the form of dividend payments. In Alliance Pharma's case, that would currently equate to about 0.01p per share.
While Alliance Pharma's payout ratio might seem fairly standard, it's worth remembering that Alliance Pharma may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 17 December 2020 (the "ex-dividend date").
Over the last 12 months, Alliance Pharma's shares have ranged in value from as little as 54.862p up to 91p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Alliance Pharma's is 0.4377. This would suggest that Alliance Pharma's shares are less volatile than average (for this exchange).
Alliance Pharma plc operates as a pharmaceutical company in the United Kingdom, Republic of Ireland, Mainland Europe, the United States, and internationally. The company acquires, markets, and distributes pharmaceutical and other medical products. It owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The company also offers medical devices, food supplements, and cosmetics. In addition, the company provides its products under the Kelo-Cote, Nizoral, MacuShield, Vamousse, Xonvea, Flamma Franchise, Aloclair, Hydromol, Forceval, Haemopressin, Optiflo, Oxyplastine, Ashton & Parsons, and Ametop brand names. Alliance Pharma plc was founded in 1996 and is headquartered in Chippenham, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.